Results 111 to 120 of about 608,859 (140)
Molecular mechanisms, crosstalk and therapeutic potential of novel acylation modifications in cardiovascular and cerebrovascular diseases. [PDF]
Li W, Ye W, Wang J, Liu Z.
europepmc +1 more source
Cuproptosis in Sepsis: Cell Type-Specific Mechanisms and Clinical Prospects. [PDF]
Fang S +6 more
europepmc +1 more source
Photoreceptor deletion of pyruvate dehydrogenase E1 subunit α1 induces retinal degeneration and reprograms retinal metabolism. [PDF]
Ma H +11 more
europepmc +1 more source
An Emerging Role for OGDHL: From Mitochondrial Energy Metabolism to Neurodevelopmental Disorders. [PDF]
Liu X, Zhang G, Yu D, Han J.
europepmc +1 more source
Dihydrolipoamide dehydrogenase (DLD, E3) is a flavoprotein common to pyruvate, α-ketoglutarate and branched-chain α-keto acid dehydrogenases. We found two novel DLD mutations (p.I40Lfs*4; p.G461E) in a 19 year-old patient with lactic acidosis and a complex amino- and organic aciduria consistent with DLD deficiency, manifesting progressive exertional ...
Michela Di Nottia +2 more
exaly +4 more sources
First Reported Lebanese Patient With Dihydrolipoamide Dehydrogenase Deficiency
Abstract: Dihydrolipoamide dehydrogenase (DLD) deficiency is an autosomal recessive metabolic disorder characterized by an unpredictable pattern of presentation and a wide phenotypic spectrum. DLD is a common constituent of multiple mitochondrial complexes. It is also known as E3 (dihydrolipoamide: NAD+ oxidoreductase, EC 1.8.1.4).
Marwa El Masri +6 more
exaly +2 more sources
The Natural History of Dihydrolipoamide Dehydrogenase Deficiency in Israel
AbstractDihydrolipoamide dehydrogenase (DLD) deficiency is an ultra‐rare autosomal‐recessive inborn error of metabolism, affecting no less than five mitochondrial multienzyme complexes. With approximately 30 patients reported to date, DLD deficiency was associated with three major clinical presentations: an early‐onset encephalopathic phenotype with ...
Orna Staretz-Chacham +2 more
exaly +3 more sources
Identification of Two Mutations in a Compound Heterozygous Child With Dihydrolipoamide Dehydrogenase Deficiency. [PDF]
An infant girl with elevated blood lactate, pyruvate, and plasma branched-chain amino acids was diagnosed with dihydrolipoamide dehydrogenase (E3; dihydrolipoamide: NAD+ oxidoreductase, EC 1.8.1.4) deficiency. Activities of the pyruvate dehydrogenase complex and E3 from patient were 26 and 2% of controls in blood lymphocytes, and 11 and 14% in cultured
Mulchand S Patel +2 more
exaly +3 more sources

